Clinical Trials Detalhe
Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose Study
Visão Geral
Gender
ALL
Idade
from 18 Years to 65 Years
Fase
PHASE3
Tipo de Estudo
INTERVENTIONAL
Localização
Hospital Garcia Da Orta (Almada, Portugal)
Centro Hospitalar de Coimbra (Coimbra, Portugal)
Hospital S.Joao (Porto, Portugal)
Clinicaltrial.gov
https://classic.clinicaltrials.gov/ct2/show/NCT01859481Sumário
Evaluation of headache response at 2 hours for active treated attacks for increasing dose.
Condições
Migraine Without Aura
Migraine With Aura
Elegibilidade
Inclusion Criteria: * Male and Female subjects in good general health, aged 18 to 65 years. * Subjects should meet IHS diagnostic criteria for migraine with or without aura. * Based on past history, subjects should expect to suffer at least one acute attack of migraine with or without aura, each 6 weeks Exclusion Criteria: * Known coronary-artery disease, clinically significant arrhythmia, heart failure, or uncontrolled hypertension. * Pregnant or lactating women. * Clinically significant electrocardiogram abnormalities at screening.